A phase 2 clinical study of KW-6500 (apomorphine hydrochloride) in patients with Parkinson's disease.
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Kyowa Hakko
- 26 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2008 New trial record.